Stockholm3 outperforms PSA for detecting significant prostate cancer
1. In this randomized screening trial, the multivariable Stockholm3 test provided greater clinical net benefit and substantially fewer false-negative results...
1. In this randomized screening trial, the multivariable Stockholm3 test provided greater clinical net benefit and substantially fewer false-negative results...
1. In this randomized trial, a comprehensive telehealth program produced modest but non-significant improvements in glycemic control compared with self-monitoring...
1. In this target trial emulation, delayed treatment of cervical intraepithelial neoplasia grade 2 (CIN 2) was associated with a...
1. In this target trial emulation, receipt of the recombinant zoster vaccine (RZV) was associated with a reduced risk of...
1. In this randomized clinical trial, a multimodal prehabilitation program for older adults undergoing spinal fusion surgery was associated with...
1. In this randomized controlled trial, tirzepatide produced substantially greater reductions in HbA1c, body weight, waist circumference, and BMI than...
1. In this randomized controlled trial, a 1 L polyethylene glycol–ascorbate regimen achieved higher rates of high-quality bowel cleansing compared...
1. In this retrospective cohort study, approximately 30% of veterans hospitalized for alcohol use disorder received medications for alcohol use...
1. In this systematic review and meta-analysis, prophylaxis with calcitonin gene-related peptide-targeting therapies (eptinezumab, erenumab, fremanezumab, galcanezumab, and atogepant) consistently...
1. In this cross-sectional study, amputation rates increased more rapidly among opioid-related than among non-opioid-related hospitalizations across the United States...
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free · only $4.16/month
Then $49.90/year. Manage renewal in your account.
Already a member? Sign in